Skip to main content
. 1999 May;47(5):557–564. doi: 10.1046/j.1365-2125.1999.00926.x

Table 2.

Number of ALS and number of ADRs (in brackets) among those patients in whom the laboratory signal could not be explained by the primary diagnosis or an underlying disease. The probability of an ADR was evaluated with the adverse reactions probability scale (APS).

graphic file with name bcp0047-0557-t2.jpg